Vai al contenuto
Claris Ventures
  • Home
  • About us
    • Strategy
    • Team
  • Portfolio
  • News
  • Careers
Cerca
Claris Ventures
Close menu
  • Home
  • About us
    • Strategy
    • Team
  • Portfolio
  • News
  • Careers
Claris Ventures
Cerca Toggle menu
Febbraio 27, 2023

Claris Ventures appoints pharmaceutical industry veteran Michael Hodges as a Partner Claris Ventures appoints pharmaceutical industry veteran Michael Hodges as a Partner […]

Claris Ventures appoints pharmaceutical industry veteran Michael Hodges as a Partner

Gennaio 28, 2023

Sibylla Biotech Raises €23 Million Series A to Advance Protein Degradation by Folding Interference Pipeline and Expand Technology Platform Sibylla Biotech Raises […]

Sibylla Biotech raises €23 Million Series A

Marzo 31, 2022

Iama Therapeutics Raises €8 Million Series A IAMA THERAPEUTICS RACCOGLIE 8 MILIONI DI EURO PER LO SVILUPPO DI UN NUOVO CANDIDATO FARMACO […]

Iama therapeutics raises €8 Million Series A

Marzo 24, 2022

Heqet Therapeutics raises €8m to advance its RNA-based therapeutic program for cardiac regeneration March 23rd, 2022 – Heqet Therapeutics, a King’s College London […]

Hequet Therapeutics raises €8 million

Marzo 24, 2022

Kither Biotech Raises €18.5 Million Series B Kither Biotech Raises €18.5 Million Series B and Appoints Dr. Vincent Metzler as Chief Executive […]

Kither Biotech Raises €18.5 Million Series B

Luglio 21, 2021

Claris Ventures announces final closing: €85m ($100m) for Italian Biotech Fund oversubscription, one year after its launch by the Turin based SGR […]

Claris Biotech I Final Closing

Marzo 9, 2021

NeoPhore Announces $21m Financing to Advance DNA Mismatch Repair Pipeline Round led by Claris Ventures with 2Invest, 3B Future Health Fund and […]

NeoPhore Announces $21m Financing to Advance DNA Mismatch Repair Pipeline

Settembre 1, 2020

Primo closing a quota €30m per Claris Biotech I, fondo biotech promosso da Claris Ventures SGR Torino, 1 settembre 2020 – Claris […]

CLARIS VENTURES LANCIA UN FONDO DEDICATO AL BIOTECH ITALIANO

Aprile 7, 2020

La rivista Prisma dedica un articolo a Claris Ventures La rivista Prisma nel mese di aprile dedica un articolo a Claris Ventures.  […]

Claris Ventures sulla rivista Prisma di Aprile

Aprile 7, 2020

Covid-19: new report from Claris Ventures on development of drugs and vaccines Claris Ventures pubblished a Vaccines & Treatments Development Snapshot for […]

COVID-19: Claris Ventures publishes its report on vaccines and drugs in development

Aprile 7, 2020

Business Insider: Claris, il primo fondo di venture capital italiano che investe solo nel biotech tricolore Ciro Spedaliere, Managing Partner of Claris […]

Business Insider: Claris, il primo fondo di venture capital italiano che investe solo nel biotech tricolore

Febbraio 14, 2020

Ciro Spedaliere from Claris Ventures in the Life Science Panel of Aifi VentureUp Forum 2020 Ciro Spedaliere, Partner of Claris Ventures, will […]

VentureUp Forum 2020

Novembre 16, 2019

Claris Ventures special guest at 39° Congresso Nazionale della Società Italiana di Farmacologia (SIF) The 39° National Congress of the Italian Pharmacology […]

Claris Ventures special guest at 39° Congresso Nazionale della Società Italiana di Farmacologia (SIF)

Ottobre 25, 2019

Claris Ventures joins Torino City Lab

Claris Ventures joins Torino City Lab

Links

  • Claris Ventures
  • Team
  • About us
  • Strategy
  • Privacy Policy
  • Terms of Service
  • Careers
  • Trasparenza
  • ESG
  • Portfolio

Contacts

Via Santa Giulia 1, Torino, Italy
+39 (0) 11 3325889
info@clarisventures.com

Arbitro per le Controversie Finanziarie

VAT: 12116290011

PEC: clarisventures.pec [at] maildoc.it

Stay in touch with Claris Ventures

Sign up for our newsletter to stay up to date on news from Claris, and our portfolio.

This website stores cookies on your computer. These cookies are used to improve your website and provide more personalized services to you, both on this website and through other media. To find out more about the cookies we use, read the privacy policy
© 2023 Claris Ventures. Proudly powered by Sydney